Seguridad y efectividad de la terapia de anticoagulación temprana en pacientes ambulatorios con COVID-19
Authors:
- Ana Gabriela Gallardo-HernándezAGAna Gabriela Gallardo-Hernández
- Rafael MoguelRMRafael Moguel
- Ana Luisa Hernández-PérezAHAna Luisa Hernández-Pérez
- Samuel Chacek-SaslavskySCSamuel Chacek-Saslavsky
- 1 January 2021
- journal article
- Published by GRAPHIMEDIC SA DE CV
- Vol. 32 (1) , 9-15
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Perfil toxicológico dos suicídios no Rio Grande do Sul, Brasil, 2017 a 2019Revista Panamericana de Salud Pública, 2021
- Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive studyThe Lancet Infectious Diseases, 2020
- The Role of Anticoagulation in COVID-19-Induced HypercoagulabilityCurrent Cardiology Reports, 2020
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-UpJACC, 2020
- Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?Thrombosis and Haemostasis, 2020
- Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before GuidelinesThrombosis and Haemostasis, 2020
- More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from ChinaEuropean Respiratory Journal, 2020
- A Review of Coronavirus Disease-2019 (COVID-19)Indian Journal of Pediatrics, 2020
- 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolismEuropean Heart Journal, 2014
- Oral Apixaban for the Treatment of Acute Venous ThromboembolismNew England Journal of Medicine, 2013